Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: A phase 2, randomised, double-blind, placebo-controlled study

Rheumatology | Sep 14, 2021 Clinical Pharmacology

Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis

The Journal of Dermatology | Sep 12, 2021 Clinical Pharmacology

Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum – A randomized clinical trial

Dermatologic Therapy | Sep 11, 2021 Clinical Pharmacology

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Journal of the American Academy of Dermatology | Sep 10, 2021 Clinical Pharmacology

Proton pump inhibitors are associated with increased risk of psoriasis: A nationwide nested case-control study

Dermatology | Sep 09, 2021 Clinical Pharmacology

Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria

Dermatologic Therapy | Sep 09, 2021 Clinical Pharmacology

Clinical outcomes of advanced-stage cutaneous lymphoma under low-dose gemcitabine treatment: Real-life data from the German Cutaneous Lymphoma Network

Dermatology | Sep 06, 2021 Clinical Pharmacology

Spinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies

Journal of the American Academy of Dermatology | Sep 01, 2021 Clinical Pharmacology

Topical 5% tranexamic acid with 30% glycolic acid peel: A useful combination for accelerating the improvement in melasma

Dermatologic Therapy | Aug 29, 2021 Clinical Pharmacology

A multi‐centre, single‐blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers

International Wound Journal | Aug 27, 2021 Clinical Pharmacology

« Prev 1 … 11 12 13 14 15 … 92 Next »

Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: A phase 2, randomised, double-blind, placebo-controlled study

Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis

Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum – A randomized clinical trial

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Proton pump inhibitors are associated with increased risk of psoriasis: A nationwide nested case-control study

Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria

Clinical outcomes of advanced-stage cutaneous lymphoma under low-dose gemcitabine treatment: Real-life data from the German Cutaneous Lymphoma Network

Spinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies

Topical 5% tranexamic acid with 30% glycolic acid peel: A useful combination for accelerating the improvement in melasma

A multi‐centre, single‐blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: A phase 2, randomised, double-blind, placebo-controlled study

Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis

Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum – A randomized clinical trial

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Proton pump inhibitors are associated with increased risk of psoriasis: A nationwide nested case-control study

Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria

Clinical outcomes of advanced-stage cutaneous lymphoma under low-dose gemcitabine treatment: Real-life data from the German Cutaneous Lymphoma Network

Spinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies

Topical 5% tranexamic acid with 30% glycolic acid peel: A useful combination for accelerating the improvement in melasma

A multi‐centre, single‐blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Select Specialty

Select Topic